Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio

INTRODUCTION: Methotrexate (MTX) constitutes the first-line therapy in rheumatoid arthritis (RA), yet approximately 30% of the patients do not benefit from MTX. Recently, we reported a prognostic multivariable prediction model for insufficient clinical response to MTX at 3 months of treatment in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosselt, Helen R., Verhoeven, Maxime M. A., de Rotte, Maurits C. F. J., Pluijm, Saskia M. F., Muller, Ittai B., Jansen, Gerrit, Tekstra, Janneke, Bulatović-Ćalasan, Maja, Heil, Sandra G., Lafeber, Floris P. J. G., Hazes, Johanna M. W., de Jonge, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695780/
https://www.ncbi.nlm.nih.gov/pubmed/32926395
http://dx.doi.org/10.1007/s40744-020-00230-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695780/
https://www.ncbi.nlm.nih.gov/pubmed/32926395
http://dx.doi.org/10.1007/s40744-020-00230-7

Ejemplares similares